PR
PRCNF.US Pure Global Cannabis Inc
- Market cap
- USD 1.62K
- P/E
- -
- P/B
- 0.01x
- ROE
- -339.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2019.
Is PRCNF.US undervalued?
Graham numberThe Graham number of Pure Global Cannabis Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Pure Global Cannabis Inc fundamental analysis
No fundamental analysis for Pure Global Cannabis Inc yet.
Pure Global Cannabis Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Pure Global Cannabis Inc
Pure Global Cannabis Inc. produces cannabis products for the medical and adult-use markets in Canada. The company provides cannabis products, such as dried flower, cannabis oils, soft gels and capsules, seedlings and clones, vape pen cartridges, topicals, sublingual strip/spray, transdermal patch, and edibles and beverages, as well as wellness products. It offers its products under the PureSinse, SPARK Medical Cannabis clinics, and The Great Canadian Hemp Company brands. The…
Full company profilePure Global Cannabis Inc financial statements
2019 annualized: Fiscal year 2019 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2019, the balance sheet is the latest quarter. Figures change when the annual report is published.
Pure Global Cannabis Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | - | 0.00 | 0.00 | 0.00 | 1.71M |
| Gross Profit | - | 0.00 | 0.00 | -136K | -485K |
| Operating Income | -193K | -228K | -903K | -5.94M | -10.7M |
| EBITDA | -256K | 377K | -903K | -17.1M | - |
| Net Income | -193K | -266K | -907K | -17.1M | -11.9M |
| EPS | -0.06 | -0.08 | -0.02 | -0.17 | -0.06 |
| Balance Sheet | |||||
| Total Assets | 36.7K | 26.3K | 26.3K | 16.3M | 17.1M |
| Total Liabilities | 303K | 737K | 370K | 9.58M | 13.6M |
| Shareholders' Equity | -266K | -711K | -344K | 6.70M | 3.51M |
| Cash & Short-term Investments | 16.3K | 99.66 | 15.4K | 5.66M | 146K |
| Total Debt | - | 10.6K | - | 8.95M | - |
| Cash Flow | |||||
| Operating Cash Flow | -54.6K | -16.1K | -278K | -6.58M | -4.88M |
| Capital Expenditure | 7.82K | 22.3K | 594K | 7.36M | 4.88M |
| Free Cash Flow | -62.4K | -38.4K | -278K | -13.9M | - |
| Ratios | |||||
| ROE | - | - | - | -255.8% | -339.0% |
| ROA | -524.7% | -1,009.0% | -3,445.3% | -105.3% | -69.6% |
| Net Profit Margin | - | - | - | - | -698.0% |
| Debt to Equity | - | - | - | 1.33x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Pure Global Cannabis Inc dividends
Pure Global Cannabis Inc has not paid dividends in the last 4 fiscal years.
Who owns Pure Global Cannabis Inc
- Insiders 16.37%
- Institutions 0.00%
- Public & others 83.64%
- Shares outstanding 162M
- Free float 133M
Pure Global Cannabis Inc company profile
- Company name
- Pure Global Cannabis Inc
- Ticker
- PRCNF.US
- ISIN
- CA74625A1075
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- December
- Address
- 418-2095 Lake Shore Boulevard West, Toronto, ON, Canada, M8V 4G4
- Phone
- 289 206 1552
- Website
- pureglobal.com
About Pure Global Cannabis Inc
Pure Global Cannabis Inc. produces cannabis products for the medical and adult-use markets in Canada. The company provides cannabis products, such as dried flower, cannabis oils, soft gels and capsules, seedlings and clones, vape pen cartridges, topicals, sublingual strip/spray, transdermal patch, and edibles and beverages, as well as wellness products. It offers its products under the PureSinse, SPARK Medical Cannabis clinics, and The Great Canadian Hemp Company brands. The company serves medical, pharmaceutical, wellness, health and beauty, natural health, food and beverage, and recreational legal markets. Pure Global Cannabis Inc. is headquartered in Toronto, Canada.
Pure Global Cannabis Inc management
7- Mr. Malay PanchalFounder, President, CEO, Treasurer & Director
- Mr. Bhupender GosainCFO & Corporate Secretary
- Ms. Trupti P. SmitDirector of Corporate & Legal Affairs
- Mr. Stephen PynnVice President of Corporate Development
- Mr. Michael LavergneHead of Global Supply Chain Services
- Ms. Li Heong Lim MAICSACompany Secretary
- Mee Kiat WongCompany Secretary